Ravindranath Nallamothu, MD
Internal Medicine · Cartersville, GANPI 1679724033
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,000 of the $3,919 with a category attached, or 76.5%. CSL Plasma Inc. accounts for 76.5% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $3,104, more than ten times the $212 reported in 2019.
Across 57 payments — averaging $68.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$3K
- Pfizer$173
- Johnson & Johnson$144
- E.r. Squibb & Sons, L.L.C.$139
- Gilead$102
- Novartis$96
- plus $265 from 8 others
What the payments were for
- Consulting fees$3,00077%
- Food & beverage$91923%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Plasma Inc. | 7 | $3,000 |
| Pfizer | 10 | $173 |
| Johnson & Johnson | 8 | $144 |
| E.r. Squibb & Sons, L.L.C. | 9 | $139 |
| Gilead | 4 | $102 |
| Novartis | 5 | $96 |
| Boehringer Ingelheim | 4 | $82 |
| Sunovion Pharmaceuticals Inc. | 3 | $63 |
| AstraZeneca | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| AbbVie | 1 | $12 |
How this compares
$3,919 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $235 |
| Digoxin | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Cartersville
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.